Skip Navigation
Skip to contents

SIDDS 2025

SIDDS 2025

Invited Speakers

Symposium Upper GI-1
Key Advances in Translational Research for Gastric Cancer

  • Genetic alterations and their role in gastric cancer development Jae Ho Cheong Yonsei University, Korea
  • Epigenetic changes in gastric tissue and cancer: Risk diagnosis and therapeutic target Toshikazu Ushijima Hoshi University, Japan
  • Biomarkers for early detection of gastric cancer Khay-Guan Yeoh National University of Singapore, Singapore CV

Symposium Liver-1
New Paradigm of MASLD Management

  • Exploring MASLD complications: Insights from Japanese clinical practices Tomomi Kogiso Tokyo Women's Medical University, Japan CV
  • Current burden and advances in therapeutics for MASLD Donghee Kim Stanford University, USA
  • Fact or fiction in the causal relationship between MASLD and cardiovascular disease Won Kim Seoul National University, Korea CV

Presidential Lecture

  • EUS-guided local therapy of pancreatic tumors Dong-Wan Seo University of Ulsan, Korea

Symposium Lower GI-1
Advanced Therapeutics in IBD: Innovations and Lessons from Evidences

  • Wise and optimal use of 5-ASAs and immunodulators Dae Sung Kim Konyang University, Korea
  • Updates on biologics: Old and new friends Alessandro Armuzzi Humanitas University, Italy
  • Small molecular agents: A paradigm shift? Eun Mi Song Ewha Womans University, Korea
  • Biosimilars: Game changers? Hyuk Yoon Seoul National University, Korea

Symposium GI Oncology-1
Recent Advances in the Management of Advanced Gastrointestinal Cancers

  • Current treatment paradigms for advanced gastric cancer Jin-Soo Kim Seoul National University, Korea
  • Advancements in colorectal cancer management Jae Hyun Kim Kosin University, Korea
  • Strategies for chemotherapy in advanced biliary tract cancer TBD TBD, TBD

Symposium Pancreatobiliary-1
Recent updates in the management of chronic pancreatitis

  • Indications and techniques for endoscopic interventions in CP Dongwook Oh University of Ulsan, Korea
  • Pancreatic enzyme replacement therapy (PERT) for pancreatic exocrine insufficiency (PEI) in patients with CP Jaihwan Kim Seoul National University, Korea CV
  • Role of surgical treatment in painful chronic pancreatitis TBD TBD, TBD

MDT-1 Upper GI, Lower GI, FGID/Motility

  • TBD TBD TBD, TBD

Symposium FGID/Motility-1
Integrative Approaches to IBS

  • 2025 IBS Seoul Consensus Hoon Sup Koo Konyang University, Korea
  • Role of microbiome and FMT in IBS Chang Hwan Choi Chung-Ang University, Korea
  • The overlap of motility disorders and irritable bowel syndrome: Mechanisms and management Nicholas Talley The University of Newcastle, Australia

PG Course - Pancreatobiliary
Optimal Treatment Strategies in Pancreatobiliary Diseases Based on Clinical Guidelines

  • Recent strategies in management of acute cholangitis Kwang Hyun Chung Soonchunhyang University, Korea
  • Recent strategies in management in acute pancreatitis Jung Wan Choe Korea University, Korea
  • Endoscopic ultrasound (EUS)-guided tissue acquisition of pancreatic solid tumors TBD TBD, TBD
  • Optimizing antithrombotic therapy for safe ERCP and EUS: Strategies for elective and emergency procedures Huapyong Kang Gachon University, Korea

PG Course - Lower GI
Current Practices to Emerging Therapies in Lower Gastrointestinal Diseases

  • Real-world medications for chronic abdominal pain Jeong Eun Shin Dankook University, Korea
  • Lower GI bleeding: How to identify and manage it Yehyun Park Ewha Womans University , Korea CV
  • Appropriated and tailored colon polypectomy: Updates from the guidelines Su Young Kim Yonsei University Wonju, Korea
  • New IBD drugs: You should know about Shin Ju Oh Kyung Hee University, Korea CV

PG Course - Upper GI
Essential Gastric Lesions: Endoscopic Approaches to Diagnosis and Treatment

  • Refractory peptic ulcer disease and its complications TBD TBD, TBD
  • Early and accurate diagnosis of Borrmann Type IV: Imaging and endoscopic strategies Jun Haeng Lee Sungkyunkwan University, Korea CV
  • Various infectious diseases in the upper GI tract Dae Young Cheung The Catholic University of Korea, Korea
  • Gastric lymphoma: Diverse endoscopic findings and management Ji Yong Ahn University of Ulsan, Korea CV

PG Course - GI Oncology
Enhancing Quality of Life in Gastrointestinal Cancer Patients

  • Addressing chemotherapy induced peripheral neuropathy to enhance quality of life in gastrointestinal cancer patients Su-Hyun Kim National Cancer Center, Korea
  • How to manage sleep disorders in cancer patients Seockhoon Chung University of Ulsan, Korea
  • Comprehensive nutritional support in gastrointestinal cancer Ji Hyung Nam Dongguk University, Korea
  • Management of gastrointestinal cancer-related emergencies Kyong Joo Lee Hallym University, Korea

KSG Session 1
Exploring the Role of Microbiome in Digestive Medicine

  • Multi-Dimensional analysis of gut microbiome: From discovery to diagnostic implementation in IBD June-Young Lee Kyung Hee University, Korea CV
  • Modulating the gut microbiome: New approaches to managing functional gastroduodenal disorders Cheol Min Shin Seoul National University, Korea
  • Mutual reactions between natural products and intestinal microorganisms in diverse mouse strains with cancer cachexia Myungsuk Kim Korea Institute of Science and Technology, Korea CV
  • Cancer microbiome in Korean patients with GI tract cancer Hansoo Park Gwangju Institute of Science and Technology, Korea

Symposium Upper GI-2
Upper Gastrointestinal Agents: Classification, Mechanisms, and Practical Prescriptions

  • Gastric acid suppressants: H2RA, PPI & P-CAB Jae Yong Park Chung-Ang University, Korea
  • Mucoprotective agents Ayoung Lee Korea University, Korea
  • Other drugs such as prokinetics, probiotics and antidepressants Seung In Seo Hallym University, Korea
  • Real-world practice of UGI drug prescription Hwoon-Yong Jung University of Ulsan, Korea

KSG Session 2
Immune Checkpoint Inhibitors in Gastroenterology and Hepatology: Innovations and Implications

  • Recent advances in immune checkpoint inhibitors for gastric cancer Tae-Yong Kim Seoul National University, Korea
  • Current status and future of immune checkpoint inhibitor treatment for hepatocellular carcinoma Sangyoun Hwang Dongnam Institute of Radiological & Medical Sciences, Korea
  • Immune checkpoint inhibitor in biliary tract cancer Joo Kyung Park Sungkyunkwan University, Korea
  • Management of the gastrointestinal adverse effects of cancer immunotherapy TBD TBD, TBD

KSG Session 3
Obesity and Sarcopenia in Gastroenterology and Hepatology: Dual Challenges in Digestive Medicine

  • Up-to-date evidences in endoscopic treatment for obesity TBD TBD, TBD
  • Sarcopenia and obesity in inflammatory bowel disease: The inflammation and nutrition nexus Jaeyoung Chun Yonsei University, Korea CV
  • Interventions for managing obesity and sarcopenia in liver cirrhosis Jae Yoon Jeong Ewha Womans University, Korea
  • High-density lipoprotein cholesterol impact on gastrointestinal cancer risk Su Youn Nam Kyungpook National University, Korea

상단으로 이동

Copyright© The Korean Society of Gastroenterology. All Rights Reserved.

Room 305, 31 Seolleung-ro 86 Gil, Gangnam-gu, Seoul, 06193, Korea
SIDDS 2025 Secretariat
30, Bamgogae-ro 1-gil, Gangnam-gu, Seoul, Korea
  • Tel. +82-2-459-8286
  • Fax. +82-2-459-8256